OpenPCR has so far shipped nearly 50 of its thermal cycler kits, each costing about $500, to high schools, biotechnology companies, and hobbyists in five continents and 13 countries.
Cloning in the kitchen? Sandra Porter checks out the DIYbio group and finds some great principles and some not-so-great biology.
The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.
Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.
In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.
Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.